Dodick, D. W., Ashina, M., Brandes, J. L., Kudrow, D., Lanteri-Minet, M., Osipova, V., . . . Lenz, R. A. (2018). ARISE: A Phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia, 38(6), 1026-1037. https://doi.org/10.1177/0333102418759786
Chicago Style (17th ed.) CitationDodick, David W., et al. "ARISE: A Phase 3 Randomized Trial of Erenumab for Episodic Migraine." Cephalalgia 38, no. 6 (2018): 1026-1037. https://doi.org/10.1177/0333102418759786.
MLA (9th ed.) CitationDodick, David W., et al. "ARISE: A Phase 3 Randomized Trial of Erenumab for Episodic Migraine." Cephalalgia, vol. 38, no. 6, 2018, pp. 1026-1037, https://doi.org/10.1177/0333102418759786.
Warning: These citations may not always be 100% accurate.